Mindfulness-based Approach Doesn’t Reduce Distress in Advanced Prostate Cancer Patients, Study Finds

Mindfulness-based Approach Doesn’t Reduce Distress in Advanced Prostate Cancer Patients, Study Finds
Patients with advanced prostate cancer don't seem to benefit from mindfulness-based cognitive therapy (MBCT) to alleviate the distress associated with their disease and treatment effects, according to a recent study published in the Journal of Clinical Oncology. The Australian study, "Mindfulness-Based Cognitive Therapy in Advanced Prostate Cancer: A Randomized Controlled Trial," shows that MBCT delivered by group teleconference has similar results compared to men who received minimally enhanced usual care. It is estimated that more than 3.8 million men are still living with prostate cancer five years after their diagnosis. According to the American Cancer Society, when all stages of prostate cancer are included, the five-year relative survival rate is almost 100 percent; the 10-year relative survival rate is 98 percent; and the 15-year rate is 95 percent. But, the study said, although most men are diagnosed with localized disease, 40 percent will eventually see their disease progress, and up to 20 percent will become castration-resistant or metastatic at some point during their disease. Acknowledging that they live with an incurable disease, together with the side effects of both the disease and its treatment, can lead to a severe reduction in quality of life, especially in advanced prostate cancer patients, according to the study, led by Suzanne K. Chambers, Ph.D., from Griffith University in Gold Coast, Australia, and colleagues. They found that patients often experience psychosocial symptoms such as depression, anxiety, and post-t
Subscribe or to access all post and page content.

One comment

Leave a Comment

Your email address will not be published. Required fields are marked *